project id: TCGA-HNSC; case submitter id: TCGA-CN-A63U; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.04; rna integrity number: 7.0; age at index: 50; days to birth: -18272; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1961; age at diagnosis: 18272; ajcc clinical m: M0; ajcc clinical n: N0; ajcc clinical stage: Stage III; ajcc clinical t: T3; ajcc pathologic m: MX; ajcc pathologic n: N2b; ajcc pathologic stage: Stage IVA; ajcc pathologic t: T3; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 964.0; icd 10 code: C32.9; last known disease status: not reported; morphology: 8070/3; primary diagnosis: Squamous cell carcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Larynx, NOS; synchronous malignancy: No; tissue or organ of origin: Larynx, NOS; tumor grade: Not Reported; year of diagnosis: 2011; alcohol history: No; cigarettes per day: 1.36986301369863; pack years smoked: 25.0; years smoked: 25.0; is ffpe: false; composition: Not Reported; days to collection: 504; days to sample procurement: 0; initial weight: 200.0; portion submitter id: TCGA-CN-A63U-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 20.0; percent normal cells: 5.0; percent stromal cells: 10.0; percent tumor cells: 80.0; percent tumor nuclei: 80.0;